Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Garca-RodrguezCEMesaMDOlzaJVlachavaMKremmydaLSDiaperNDet al
Going more than 14 days without a GLP-1 dose may require medical guidance before safely restarting your medication
No previously approved obesity medication has cleared two thirds of its high-dose arm out of clinical obesity
ABSTRACT: Glucagon-like peptide-1 (GLP-1) receptor agonists are an increasingly popular class of glucose-lowering agents for the treatment of type 2 diabetes (T2DM), owing to their robust glucose-lowering effects, low risk of hypoglycemia, and potential to induce weight loss
New Engl J Med (2017) 377(13):122839
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
